3,274
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Ethical decision-making in biopharmaceutical research and development: applying values using the TRIP & TIPP model

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1981-1988 | Received 30 Sep 2019, Accepted 26 Nov 2019, Published online: 15 Jan 2020

References

  • Mills AE, Spencer EM. Values based decision making: a model for achieving the goals of healthcare. HEC Forum. 2005;17:18–32.
  • McCartney JJ. Values based decision making in healthcare: introduction. HEC Forum. 2005;17(1):1–5. doi:10.1007/s10730-005-4946-4.
  • Kotalik J, Covino C, Doucette N, Henderson S, Langlois M, McDaid K, Pedri LM. Framework for ethical decision making based on mission, vision and values of the institution. HEC Forum. 2014;26(2):125–33. doi:10.1007/s10730-014-9235-7.
  • International Federation of Pharmaceutical Manufacturers & Associations. Code of practice: upholding ethical standards and sustaining trust. 2019 [accessed 2019 Jul 4]. https://www.ifpma.org/wp-content/uploads/2018/09/IFPMA_Code_of_Practice_2019.pdf
  • Eli Lilly and Company. Who we are. 2019 [accessed 2019 Jul 4]. https://www.lilly.com/who-we-are
  • Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Our values. 2019 [accessed 2019 Jul 4]. https://www.merck.com/about/our-values/
  • Novartis AG. Our culture and values help us fulfill our purpose. 2019 [accessed 2019 Jul 4]. https://www.novartis.com/our-company/our-culture-and-values
  • GSK group of companies. Our culture and values. 2018 [accessed 2019 Jul 4]. https://uk.gsk.com/en-gb/careers/working-at-gsk/our-culture-and-values/
  • Bonde S, Briant C, Firenze P, Hanavan J, Huang A, Li M, Narayanan C, Parthasarathy C, Zhao H. Making choices: ethical decisions in a global context. Sci Eng Ethics. 2016;22:343–66. doi:10.1007/s11948-015-9641-5.
  • Markkula Centre for Applied Ethics. A framework for ethical decision making. 2009 May [accessed 2019 Jul 4]. https://www.scu.edu/ethics/ethics-resources/ethical-decision-making/a-framework-for-ethical-decision-making/
  • Ling TJ, Hauke JM. The ETHICS model: comprehensive, ethical decision making. Paper based on a program presented at: 2016 American Counseling Association Conference; 2016 April 3; Montréal, Québec. [accessed 2019 Jul 4]. https://www.counseling.org/docs/default-source/vistas/the-ethics-model.pdf
  • Ferrell OC, Fraedrich J, Ferrell L. Business ethics: ethical decision making & cases. Vol. 12, Boston (MA): Cengage Learning; 2018.
  • Mackie JE, Taylor AD, Finegold DL, Daar AS, Singer PA. Lessons on ethical decision making from the bioscience industry. PLoS Med. 2006;3(5):605–10. doi:10.1371/journal.pmed.0030129.
  • Finegold D, Moser A. Ethical decision making in bioscience firms. Nat Biotechnol. 2006;24(3):285–90. doi:10.1038/nbt0306-285.
  • Finegold DL, Bensimon CM, Daar AS, Eaton ML, Godard B, Knoppers BM, Mackie JE, Singer PA. Bioindustry ethics. New York (USA): Elsevier Academic Press; 2005.
  • Van Campen LE, Therasse DG, Klopfenstein M, Levine RJ, Lilly E. Company’s bioethics framework for human biomedical research. Curr Med Res Opin. 2015;31(11):2081–93. doi:10.1185/03007995.2015.1087987.
  • Merck CE. Vioxx: an examination of an ethical decision-making model. J Bus Ethics. 2007;76:451–61. doi:10.1007/s10551-006-9302-3.
  • Hartman L, Metselaar S, Widdershoven G, Molewijk B. Developing a ‘moral compass tool’ based on moral case deliberations: A pragmatic hermeneutic approach to clinical ethics. Bioethics. 2019;33(9):1012–1021. doi:10.1111/bioe.12617.
  • Giacomini M, Kenny N, DeJean D. Ethics frameworks in Canadian health policies: foundation, scaffolding, or window dressing? Health Policy. 2009;89:58–71. doi:10.1016/j.healthpol.2008.04.010.
  • Keeney RL. Decision analysis: an overview. Oper Res. 1982;30(5):803–38. doi:10.1287/opre.30.5.803.
  • Guo KL. DECIDE: A decision-making model for more effective decision making by health care managers. Health Care Manag. 2008;27(2):118–27. doi:10.1097/01.HCM.0000285046.27290.90.
  • Bradley R. Decision Theory: a formal philosophical introduction. London (England): London School of Economics and Political Science; 2014.
  • Rest JR, Barnett R. Moral development: advances in research and theory. New York (NY): Praeger; 1986.
  • James PS. Aligning and propagating organizational values. Procedia Econ Financ. 2014;11:95–109. doi:10.1016/S2212-5671(14)00180-4.
  • Rasoal D, Skovdahl K, Gifford M, Kihlgren A. Clinical ethics support for healthcare personnel: an integrative literature review. HEC Forum. 2017;29:313–46. doi:10.1007/s10730-017-9325-4.
  • Haan MM, van Gurp JLP, Naber SM, Groenewoud AS. Impact of moral case deliberation in healthcare settings: a literature review. BMC Med Ethics. 2018;19:85. doi:10.1186/s12910-018-0325-y.
  • Stolper M, Metselaar S, Molewijk B, Widdershoven G. Moral case deliberation in an academic hospital in the Netherlands. J Int Bioethique. 2012;23(3–4):53–66. doi:10.3917/jib.233.0053.
  • Crossan M, Mazutis D, Seijts G. In search of virtue: the role of virtues, values and character strengths in ethical decision making. J Bus Ethics. 2013;113:567–81. doi:10.1007/s10551-013-1680-8.
  • Khalid K, Eldakak SE, Loke S-P. A structural approach to ethical reasoning: the integration of moral philosophy. Acad Strateg Manag J. 2017;16:81–113.
  • Arjoon S. Ethical decision-making: a case for the triple font theory. J Bus Ethics. 2007;71(4):395–410. doi:10.1007/s10551-006-9142-1.
  • Wright-St Clair VA, Newcombe DB. Values and ethics in practice-based decision making. Can J Occup Ther. 2014;81(3):154–62. doi:10.1177/0008417414535083.
  • Berling E, McLeskey C, O’Rourke M, Pennock RT. A new method for a virtue‑based responsible conduct of research curriculum: pilot test results. Sci Eng Ethics. 2019;25(3):899–910. doi:10.1007/s11948-017-9991-2.
  • McLeskey CM, Berling EW, O’Rourke M, Pennock RT. Reviewing the responsible conduct of research (RCR) literature from a scientific virtue perspective. Presentation at: World Congress of Research Integrity; 2017 May 28–31; Amsterdam, Netherlands.
  • Jones TM. Ethical decision making by individuals in organizations: an issue-contingent model. Acad Manage Rev. 1991;16(2):366–95. doi:10.5465/amr.1991.4278958.
  • Jones J. Leadership lessons from Levinas: revisiting responsible leadership. Leadersh Humanities. 2014;2(1):44–63. doi:10.4337/lath.
  • Nulty DD. The adequacy of response rates to online and paper surveys: what can be done? Assess Eval High Educ. 2008;33(3):301–14. doi:10.1080/02602930701293231.
  • Clouser KD, Gert B. A critique of principlism. J Med Philos. 1990;15(2):219–36. doi:10.1093/jmp/15.2.219.
  • Beauchamp TL, Childress JF. Principles of biomedical ethics. 5th ed. New York, NY: Oxford University Press; 2001.
  • Caplan AL, Teagarden JR, Kearns L, Bateman-House AS, Mitchell E, Arawi T, Upshur R, Singh I, Rozynska J, Cwik V, et al. Fair, just and compassionate: a pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials. J Med Ethics. 2018;44:761–67. doi:10.1136/medethics-2016-103917.
  • Ott MA, Crawley FP, Sáez-Llorens X, Owusu-Agyei S, Neubauer D, Dubin G, Poplazarova T, Begg N, Rosenthal SL. Ethical considerations for the participation of children of minor parents in clinical trials. Pediatr Drugs. 2018 Jun;20(3):215–22. doi:10.1007/s40272-017-0280-y.